June 2013 FDA Recall Drug by Fresenius Kabi Usa, Llc
D-804-2013 - Subpotent Drug; 15-month stability test station

This Class II drug recall was voluntarily initiated by Fresenius Kabi Usa, Llc on June 24, 2013 for the product Drug. The FDA reported the reason for recall as subpotent drug; 15-month stability test station. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-804-2013

Reason for Recall
Subpotent Drug; 15-month stability test station
Initiated
06-24-2013
Reported
07-24-2013
Quantity
221,600 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Fresenius Kabi USA, LLC
Nationwide and Puerto Rico
Oxytocin Injection, USP, (Synthetic), 10 USP Units/mL, for IV Infusion or IM Use, Rx Only, 1 mL vial, APP ) 10 USP Units/mL, 1 mL, APP Pharmaceuticals, LLC Schaumburg, IL, 60173, NDC 63323-012-01.

Batch or Lot Expiration Information

Lot# : 6003648, Exp. 6/2013